UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Journal of clinical oncology, 2009-12, Vol.27 (34), p.5794-5799

2009

Volltextzugriff (PDF)

Phase III Trial Comparing Concurrent Biochemotherapy With Cisplatin, Vinblastine, Dacarbazine, Interleukin-2, and Interferon Alfa-2b With Cisplatin, Vinblastine, and Dacarbazine Alone in Patients With Metastatic Malignant Melanoma (E3695): A Trial Coordinated by the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5748-5754

2008

Volltextzugriff (PDF)

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Journal of clinical oncology, 2004-03, Vol.22 (5), p.909-918

2004

Volltextzugriff (PDF)

BRAF Mutations in Metanephric Adenoma of the Kidney

European urology, 2012-11, Vol.62 (5), p.917-922

2012

Volltextzugriff (PDF)

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings

Radiology, 2009-03, Vol.250 (3), p.793-802

2009

Volltextzugriff (PDF)

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Journal of clinical oncology, 2001-08, Vol.19 (16), p.3622-3634

2001

Volltextzugriff (PDF)

Multicenter phase ii trial of high-dose imatinib mesylate in metastatic melanoma : Significant toxicity with no clinical efficacy

Cancer, 2006-05, Vol.106 (9), p.2005-2011

2006

Volltextzugriff (PDF)

Angiopoietin 2 Is a Potential Mediator of High-Dose Interleukin 2–Induced Vascular Leak

Clinical cancer research, 2007-04, Vol.13 (7), p.2115-2120

2007

Volltextzugriff (PDF)

Long-Term Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Cutaneous Melanoma: Results of a United States Case–Control Study

Journal of investigative dermatology, 2011-07, Vol.131 (7), p.1460-1468

2011

Volltextzugriff (PDF)

Cytokine Working Group Study of Lymphodepleting Chemotherapy, Interleukin-2, and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma: Clinical Outcomes and Peripheral-Blood Cell Recovery

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1196-1202

2010

Volltextzugriff (PDF)

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear‐cell renal cell carcinoma receiving vascular endothelial growth factor‐targeted therapy

BJU international, 2010-09, Vol.106 (6), p.772-778

2010

Volltextzugriff (PDF)

A phase 2 pilot trial of low‐dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma

Cancer, 2010-04, Vol.116 (7), p.1751-1756

2010

Volltextzugriff (PDF)

Temozolomide, Thalidomide, and Whole Brain Radiation Therapy for Patients With Brain Metastasis From Metastatic Melanoma : A Phase II Cytokine Working Group Study

Cancer, 2008-10, Vol.113 (8), p.2139-2145

2008

Volltextzugriff (PDF)

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma

Urologic oncology, 2011-11, Vol.29 (6), p.756-763

2011

Volltextzugriff (PDF)

Prospective evaluation of analgesic use and risk of renal cell cancer

Archives of internal medicine (1960), 2011-09, Vol.171 (16), p.1487

2011

Volltextzugriff (PDF)

Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12

Journal of immunotherapy, 2001-01, Vol.24 (1), p.91-98

2001

Volltextzugriff (PDF)

Liver metastases from melanoma: detection with multiphasic contrast-enhanced CT

Radiology, 1999-10, Vol.213 (1), p.92-96

1999

Volltextzugriff (PDF)

Interleukin-6-associated anemia : determination of the underlying mechanism

Blood, 1995-08, Vol.86 (4), p.1288-1291

1995

Volltextzugriff (PDF)

A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor

Clinical cancer research, 1998-05, Vol.4 (5), p.1203-1213

1998

Volltextzugriff (PDF)

High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma

JNCI : Journal of the National Cancer Institute, 1990-07, Vol.82 (14), p.1202-1206

1990

Volltextzugriff (PDF)

Local excision of rectal carcinoma : early results with combined chemoradiation therapy using 5-fluorouracil and leucovorin

Diseases of the colon & rectum, 1994-04, Vol.37 (4), p.308-312

1994

Volltextzugriff (PDF)

Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1698-1704

2007

Volltextzugriff (PDF)

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial

JAMA : the journal of the American Medical Association, 2012-05, Vol.307 (18), p.1925

2012

Volltextzugriff (PDF)

Possible myocardial toxicity associated with interleukin-4 therapy

Journal of immunotherapy (1997), 1993-11, Vol.14 (4), p.348-351

1993

Volltextzugriff (PDF)

Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3542-3547

2006

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

KollektionAUTh Library subscriptions: Taylor & Francis Journals

ThemaImmunotherapy

ThemaAged

ThemaBiological And Medical Sciences

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Life Sciences & Biomedicine
(35)
Male
(35)
Medical Sciences
(35)
Science & Technology
(35)
Middle Aged
(33)
Adult
(23)
Oncology
(22)
Aged, 80 And Over
(14)
Tumors
(14)
Treatment Outcome
(10)
Nephrology. Urinary Tract Diseases
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Pharmacology. Drug Treatments
(8)
Carcinoma, Renal Cell - Drug Therapy
(7)
Dermatology
(7)
Kidney Neoplasms - Drug Therapy
(7)

12 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

BRAF Mutations in Metanephric Adenoma of the Kidney

Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Multicenter phase ii trial of high-dose imatinib mesylate in metastatic melanoma : Significant toxicity with no clinical efficacy

Angiopoietin 2 Is a Potential Mediator of High-Dose Interleukin 2–Induced Vascular Leak

Long-Term Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Cutaneous Melanoma: Results of a United States Case–Control Study

Cytokine Working Group Study of Lymphodepleting Chemotherapy, Interleukin-2, and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma: Clinical Outcomes and Peripheral-Blood Cell Recovery

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear‐cell renal cell carcinoma receiving vascular endothelial growth factor‐targeted therapy

A phase 2 pilot trial of low‐dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma

Temozolomide, Thalidomide, and Whole Brain Radiation Therapy for Patients With Brain Metastasis From Metastatic Melanoma : A Phase II Cytokine Working Group Study

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma

Prospective evaluation of analgesic use and risk of renal cell cancer

Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12

Liver metastases from melanoma: detection with multiphasic contrast-enhanced CT

Interleukin-6-associated anemia : determination of the underlying mechanism

A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor

High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell Carcinoma

Local excision of rectal carcinoma : early results with combined chemoradiation therapy using 5-fluorouracil and leucovorin

Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial

Possible myocardial toxicity associated with interleukin-4 therapy

Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144

Aktive Filter

Suchergebnisse filtern